Health-related QoL Following TAVI TAo, TAVI TF and AVR
Completed
- Conditions
- Quality of Life
- Registration Number
- NCT03583398
- Lead Sponsor
- Medical University of Gdansk
- Brief Summary
The aim of the study was to evaluate short- and long-term changes in QoL in patients undergoing TAVI and to assess differences in patient QoL when using the TAVI TAo approach compared with the transfemoral approach (TAVI TF) and surgical aortic valve replacement (SAVR).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 97
Inclusion Criteria
- aortic valve stenosis
Exclusion Criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Health-related quality of life: EQ-5D-3L questionnaire 1 month and 1 year follow-up EQ-5D-3L questionnaire
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie QoL improvements after TAVI TAo versus TAVI TF and SAVR?
How does TAVI TAo compare to TAVI TF and SAVR in managing aortic stenosis-related adverse events?
What biomarkers predict optimal patient selection for TAVI TAo, TAVI TF, or SAVR in aortic valve disease?
Are there specific drug-eluting valve coatings that enhance outcomes in TAVI TAo or TAVI TF procedures?
What are the long-term comparative effectiveness data for transaortic vs. transfemoral TAVI and SAVR in elderly patients?